Centre Médical de l'Institut Pasteur
Paris, 75015, France
Location status: Recruiting
NCT Number: NCT03357536
Listeriosis is a rare, severe foodborne infection, responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor.
The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae).
The aim of the study is to identify genetic susceptibility to Listeriosis.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Paris, 75015, France
Location status: Recruiting
Listeriosis is a rare, severe foodborne infection caused by the bacterium Listeria monocytogenes (Lm), responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor.
The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae).
The analysis of the genetically transmitted vulnerability of Lm has not yet been studied, because of the lack of accessibility to prospective cohorts (and their DNA) for this rare and severe infection.
The aim of the study is to identify genetic susceptibility to Listeriosis that will optimize the patient care in terms of treatment and prevention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for patients with Listeriosis :
Inclusion criteria
for volunteers related to patients with Listeriosis (after identifying a genetic susceptibility in the patient with Listeriosis) :
Exclusion criteria
for volunteers related to patients with Listeriosis:
Time frame: 10 years
In patients with Listeriosis, the hypothesis that the identified genetic variation is the mutation responsible for the infection will be verified :
Time frame: 10 years
In patients with Listeriosis, the susceptibility factor associated with the most severe or atypical forms will be characterized :
Contact information is provided by the study sponsor or research team.
Caroline Charlier-Woerther
CONTACT
Marc Lecuit
CONTACT
Institut Pasteur
Industry
Genetic Susceptibility to Listeriosis - Listeria-GEN
Acronym: Listeria-GEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01520597
Bacterial Infections, Bacterial Infections and Mycoses
Paris, France
View Trial DetailsNCT02924220
Bacterial Infections, Bacterial Infections and Mycoses
Paris, France
View Trial DetailsNCT06479837
Bacterial Infections, Bacterial Infections and Mycoses
Bethesda, Maryland, United States
View Trial DetailsNCT05069688
Actinomycetales Infections, Bacterial Infections
Ibadan, Oyo State, Nigeria
View Trial Details